albendazole has been researched along with Epilepsy in 29 studies
Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the response to albendazole treatment in patients who had SSECTL and new onset seizures treated with antiepileptic drugs (AED) in a prospective clinical trial." | 9.13 | Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. ( Chattopadhyay, A; Khandelwal, N; Sawhney, IM; Thussu, A, 2008) |
| "Ten cases of cerebral cysticercosis, treated with 2-week course of albendazole, were reported." | 7.68 | Treatment of neurocysticercosis with a two week course of albendazole. ( Chotmongkol, V, 1993) |
| "To evaluate the response to albendazole treatment in patients who had SSECTL and new onset seizures treated with antiepileptic drugs (AED) in a prospective clinical trial." | 5.13 | Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. ( Chattopadhyay, A; Khandelwal, N; Sawhney, IM; Thussu, A, 2008) |
| "18 patients with partial epilepsy and neurocysticercosis were treated with albendazol or praziquantel and followed from 3 months to 12 years." | 5.09 | Cysticidal therapy: impact on seizure control in epilepsy associated with neurocysticercosis. ( Cardoso, TM; Cendes, F; Guerreiro, CA; Kobayashi, E; Santos, IC, 2000) |
| " Lastly, widespread neurocysticercosis may be a concern in mass treatment programs that provide praziquantel (for managing schistosomiasis) or albendazole (for managing intestinal worms or lymphatic filariasis) because these drugs may kill cerebral cysticerci, resulting in severe adverse events." | 3.74 | Could neurocysticercosis be the cause of "onchocerciasis-associated" epileptic seizures? ( Eberhard, M; Habumogisha, P; Katabarwa, M; Lakwo, T; Richards, F, 2008) |
| "Ten cases of cerebral cysticercosis, treated with 2-week course of albendazole, were reported." | 3.68 | Treatment of neurocysticercosis with a two week course of albendazole. ( Chotmongkol, V, 1993) |
| "Seizures are the commonest manifestation of brain parenchymal cysticercosis." | 2.55 | Controversies in the treatment of seizures associated with neurocysticercosis. ( Sharma, R; Singh, G, 2017) |
| "Neurocysticercosis is the most important parasitic infection of the nervous system in countries of the third world." | 2.38 | Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy. ( Overbosch, D, 1992) |
| "Strongyloidiasis is an infestation caused by the intestinal nematode Strongyloides stercoralis." | 1.56 | Central Nervous System Strongyloides Stercoralis. A Case Report. ( Demirtas, E; Oktar, N; Ozer, HM, 2020) |
| "Epilepsy is the main revealing symptom." | 1.31 | [Diagnosis of neurocysticercosis: a case report]. ( Andriamamonjy, C; Andriantsimahavandy, A; Rajaonarison, P; Ralamboson, S; Ramanampamonjy, R; Ramanantoanina, CE; Razafindratrimo, F; Villeneuve, R, 2001) |
| "After medical treatment of neurocysticercosis, there is usually remission or marked improvement in the associated seizure disorder." | 1.28 | The course of seizures after treatment for cerebral cysticercosis. ( Sotelo, J; Vazquez, V, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (31.03) | 18.2507 |
| 2000's | 8 (27.59) | 29.6817 |
| 2010's | 9 (31.03) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Takayanagui, OM | 1 |
| Haes, TM | 1 |
| Bossi, G | 1 |
| Bruno, R | 1 |
| Novati, S | 1 |
| Maserati, R | 1 |
| Mussati, G | 1 |
| Gorone, MP | 1 |
| Nepita, EV | 1 |
| Regalbuto, C | 1 |
| Gola, G | 1 |
| Simoncelli, AM | 1 |
| Bruno, A | 1 |
| Musso, P | 1 |
| Clerici, E | 1 |
| Marseglia, GL | 1 |
| Garcia, HH | 1 |
| Del Brutto, OH | 2 |
| Singh, G | 1 |
| Sharma, R | 1 |
| Heller, T | 1 |
| Wallrauch, C | 1 |
| Kaminstein, D | 1 |
| Phiri, S | 1 |
| Oktar, N | 1 |
| Ozer, HM | 1 |
| Demirtas, E | 1 |
| Villela, VA | 1 |
| Dixon, AM | 1 |
| Steele, R | 1 |
| Nalini, A | 2 |
| de Souza, A | 2 |
| Saini, J | 1 |
| Thennarasu, K | 2 |
| Segamwenge, IL | 1 |
| Kioko, NP | 1 |
| Mouhari-Toure, A | 1 |
| N'Timon, B | 1 |
| Kumako, V | 1 |
| Darre, T | 1 |
| Saka, B | 1 |
| Tchaou, M | 1 |
| Amegbor, K | 1 |
| Kombate, K | 1 |
| Balogou, AA | 1 |
| Pitche, P | 1 |
| Bugeme, M | 1 |
| Mukuku, O | 1 |
| Rajshekhar, V | 2 |
| Yeshraj, G | 1 |
| Kovoor, JM | 1 |
| Rajaonarison, P | 1 |
| Ralamboson, S | 1 |
| Andriamamonjy, C | 1 |
| Ramanampamonjy, R | 1 |
| Ramanantoanina, CE | 1 |
| Razafindratrimo, F | 1 |
| Villeneuve, R | 1 |
| Andriantsimahavandy, A | 1 |
| van der Meer, P | 1 |
| Quant-Durán, C | 1 |
| Thussu, A | 1 |
| Chattopadhyay, A | 1 |
| Sawhney, IM | 1 |
| Khandelwal, N | 1 |
| Katabarwa, M | 1 |
| Lakwo, T | 1 |
| Habumogisha, P | 1 |
| Richards, F | 1 |
| Eberhard, M | 1 |
| Padma, MV | 1 |
| Behari, M | 1 |
| Misra, NK | 1 |
| Ahuja, GK | 1 |
| Monteiro, L | 2 |
| Almeida-Pinto, J | 1 |
| Stocker, A | 1 |
| Sampaio-Silva, M | 1 |
| Chotmongkol, V | 1 |
| Carpio, A | 1 |
| Escobar, A | 1 |
| Hauser, WA | 1 |
| Lopes, J | 1 |
| Martins da Silva, A | 1 |
| Morales, NM | 1 |
| Agapejev, S | 1 |
| Morales, RR | 1 |
| Padula, NA | 1 |
| Lima, MM | 1 |
| Santos, IC | 1 |
| Kobayashi, E | 1 |
| Cardoso, TM | 1 |
| Guerreiro, CA | 1 |
| Cendes, F | 1 |
| Vazquez, V | 1 |
| Sotelo, J | 1 |
| Overbosch, D | 1 |
| Puri, V | 1 |
| Sharma, DK | 1 |
| Kumar, S | 1 |
| Choudhury, V | 1 |
| Gupta, RK | 1 |
| Khalil, A | 1 |
8 reviews available for albendazole and Epilepsy
| Article | Year |
|---|---|
Update on the diagnosis and management of neurocysticercosis.
Topics: Albendazole; Epilepsy; Humans; Magnetic Resonance Imaging; Neurocysticercosis; Praziquantel | 2022 |
Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
Topics: Albendazole; Anticestodal Agents; Antiparasitic Agents; Brain; Cysts; Epilepsy; Female; Humans; Infl | 2017 |
Controversies in the treatment of seizures associated with neurocysticercosis.
Topics: Adrenal Cortex Hormones; Albendazole; Anticonvulsants; Choice Behavior; Consensus; Epilepsy; Granulo | 2017 |
[Disseminated cysticercosis: report of three cases in Togo].
Topics: Albendazole; Animals; Anthelmintics; Anticonvulsants; Betamethasone; Cysticercosis; Epilepsy; Eye In | 2015 |
Neurocysticercosis: Diagnostic problems & current therapeutic strategies.
Topics: Albendazole; Animals; Brain; Epilepsy; Humans; India; Neurocysticercosis; Red Meat; Swine; Taenia so | 2016 |
Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients.
Topics: Adolescent; Adult; Albendazole; Animals; Antibodies, Helminth; Brain Diseases; Cerebrospinal Fluid S | 1993 |
Cysticercosis and epilepsy: a critical review.
Topics: Albendazole; Anthelmintics; Antiplatyhelmintic Agents; Brain; Brain Diseases; Clinical Trials as Top | 1998 |
Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy.
Topics: Albendazole; Central Nervous System Diseases; Cimetidine; Cysticercosis; Diagnosis, Differential; Di | 1992 |
5 trials available for albendazole and Epilepsy
| Article | Year |
|---|---|
Quantitative serial T2 relaxometry: a prospective evaluation in solitary cerebral cysticercosis.
Topics: Albendazole; Algorithms; Anthelmintics; Anticonvulsants; Drug Therapy, Combination; Epilepsy; Female | 2014 |
Randomized controlled trial of albendazole in new onset epilepsy and MRI confirmed solitary cerebral cysticercal lesion: effect on long-term seizure outcome.
Topics: Adolescent; Adult; Albendazole; Analysis of Variance; Cerebral Cortex; Child; Double-Blind Method; E | 2009 |
Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Carbamazepine; Cerebral Cortex; Child; Child, Prescho | 2008 |
Albendazole in single CT ring lesions in epilepsy.
Topics: Adolescent; Adult; Albendazole; Child; Child, Preschool; Contrast Media; Double-Blind Method; Epilep | 1994 |
Cysticidal therapy: impact on seizure control in epilepsy associated with neurocysticercosis.
Topics: Adult; Aged; Albendazole; Anticestodal Agents; Epilepsy; Follow-Up Studies; Humans; Magnetic Resonan | 2000 |
16 other studies available for albendazole and Epilepsy
| Article | Year |
|---|---|
Cerebral Toxocariasis as a Cause of Epilepsy: A Pediatric Case.
Topics: Albendazole; Animals; Antiparasitic Agents; Brain Abscess; Central Nervous System Helminthiasis; Chi | 2021 |
Case Report: Cysticercosis: Sonographic Diagnosis of a Treatable Cause of Epilepsy and Skin Nodules.
Topics: Adult; Albendazole; Animals; Brain; Cysticercosis; Epilepsy; Female; Humans; Muscle, Skeletal; Prazi | 2017 |
Central Nervous System Strongyloides Stercoralis. A Case Report.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Brain; Epilepsy; Female; Humans; Strongyloides ster | 2020 |
Health Care Without Borders: A Case Report of an Immigrant Child Who Lost His Voice.
Topics: Adolescent; Albendazole; Anthelmintics; Anticonvulsants; Brain; Brain Diseases; Emigrants and Immigr | 2019 |
Difficult to control epilepsy in young female: a common problem in a low resource setting.
Topics: Adolescent; Albendazole; Anthelmintics; Anticonvulsants; Brain; Calcinosis; Drug Resistance; Epileps | 2014 |
[Neurocysticercosis revealed by refractory epilepsy: report of a case].
Topics: Adult; Albendazole; Epilepsy; Humans; Male; Neurocysticercosis; Prednisolone | 2015 |
[Diagnosis of neurocysticercosis: a case report].
Topics: Aged; Albendazole; Anthelmintics; Dysarthria; Endemic Diseases; Enzyme-Linked Immunosorbent Assay; E | 2001 |
[Diagnostic image (174). A Nicaraguan man with an epileptic seizure. Neurocysticercosis].
Topics: Albendazole; Anthelmintics; Epilepsy; Food Contamination; Food Parasitology; Humans; Male; Middle Ag | 2004 |
Could neurocysticercosis be the cause of "onchocerciasis-associated" epileptic seizures?
Topics: Albendazole; Animals; Anthelmintics; Epilepsy; Humans; Neurocysticercosis; Onchocerca; Onchocerciasi | 2008 |
Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis.
Topics: Adolescent; Adult; Albendazole; Brain Diseases; Child; Cysticercosis; Epilepsy; Female; Humans; Male | 1994 |
Treatment of neurocysticercosis with a two week course of albendazole.
Topics: Adolescent; Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; Epileps | 1993 |
Relationship between cysticercosis and epilepsy.
Topics: Albendazole; Animals; Anthelmintics; Anticestodal Agents; Drug Administration Schedule; Epilepsy; Hu | 1999 |
Clinical aspects of neurocysticercosis in children.
Topics: Albendazole; Anthelmintics; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Eosinophils; Epil | 2000 |
Cerebral cysticercus granuloma associated with a subdural effusion.
Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Epilepsy; Female; Granuloma; Humans; Magnetic Res | 2001 |
The course of seizures after treatment for cerebral cysticercosis.
Topics: Adult; Albendazole; Brain; Brain Diseases; Cysticercosis; Epilepsy; Female; Follow-Up Studies; Human | 1992 |
Neurocysticercosis in children.
Topics: Adolescent; Albendazole; Brain Diseases; Child; Child, Preschool; Cysticercosis; Drug Therapy, Combi | 1991 |